Clik here to view.
Experimental diabetes drug performs well in clinical trials
An experimental new diabetes drug, lixisenatide, combined with Lantus, helped patients better control the level of sugar in their blood, according to results from a phase three clinical trial sponsored...
View ArticleClik here to view.
New drug could offer more treatment options for type 2 diabetes
French drug maker Sanofi has won approval from European authorities to market the type 2 diabetes drug lixisenatide, which will be sold under the brand name Lyxumia. The Food and Drug Administration...
View ArticleClik here to view.
FDA to review new type 2 diabetes treatment
The Food and Drug Administration (FDA) has started a review of Sanofi’s new once-daily type 2 diabetes drug lixisenatide. The drug was approved last month by European Union regulators, and will be...
View ArticleClik here to view.
European drug regulators investigate pancreas risks with popular type 2...
The European Medicines Agency is investigating whether a class of type 2 diabetes medications increases the risk of pancreatitis (inflammation of the pancreas) and precancerous cellular changes called...
View ArticleSanofi ready to submit new type 2 diabetes drug for approval
After years of delay, drug maker Sanofi is almost ready to resubmit its type 2 diabetes treatment lixisenatide for Food and Drug Administration (FDA) approval, armed with a long-term study that the...
View Article
